Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Mayinglong Pharmaceutical Group Co Ltd
EPS (Diluted)
Mayinglong Pharmaceutical Group Co Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
|
EPS (Diluted)
¥1
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
10%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
EPS (Diluted)
¥0
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
EPS (Diluted)
¥4
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
EPS (Diluted)
¥2
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
EPS (Diluted)
¥0
|
CAGR 3-Years
6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
See Also
What is Mayinglong Pharmaceutical Group Co Ltd's EPS (Diluted)?
EPS (Diluted)
1.1
CNY
Based on the financial report for Sep 30, 2023, Mayinglong Pharmaceutical Group Co Ltd's EPS (Diluted) amounts to 1.1 CNY.
What is Mayinglong Pharmaceutical Group Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
10%
Over the last year, the EPS (Diluted) growth was -6%. The average annual EPS (Diluted) growth rates for Mayinglong Pharmaceutical Group Co Ltd have been 7% over the past three years , 18% over the past five years , and 10% over the past ten years .